6108 — New Ray Medicine International Holding Share News
0.000.00%
Last trade - 00:00- HK$46.54m
- -HK$24.92m
- HK$130.37m
Brief: New Ray Medicine International Holding Sees Profit Attributable For Year
Brief: New Ray Medicine International Holding Updates On Trading Resumption
Brief: New Ray Medicine International Holding Posts HY Net Loss Attributable Of HK$52.4 Mln
Brief: New Ray Medicine International Expects Loss On Equity Instruments On Listed Securities In HY
Brief: New Ray Medicine International Holding Updates On Recent Development Of Suspension
Brief: New Ray Medicine International Updates On Amendments To Delisting Framework
Brief: New Ray Medicine International Holding Appoints Huo Zhihong As Chief Executive Officer
Brief: New Ray Medicine International Holding Posts FY Net Loss Attributable Of HK$105 Mln
Brief: New Ray Medicine International Holding Sees Impairment Losses On Group's AFS Investments
Brief: New Ray Medicine International Holding Sees Increase In FY Loss
Brief: Trading in shares of New Ray Medicine International suspended
Brief: New Ray Medicine International says HY net loss attributable was about HK$52.4 mln
Brief: New Ray Medicine International updates on disposal of Rui Kang Pharmaceutical Group Investments
Brief: New Ray Medicine International expects increase in loss for HY ended 30 June 2017
Brief: New Ray Medicine International Holding says Lee Chik Yuet retired as executive director
Brief: New Ray Medicine International acquired aggregate of 120 mln TH shares in open market
Brief: New Ray Medicine International says purchaser and vendor entered into SPA
Brief: New Ray Medicine International enters into deed of termination
Brief: China Wah Yan Healthcare says New Ray Medicine to raise HK$330 mln by rights issue